Personalized Gut Microbiome Modulation and Iron Supplement System
Legal Citation
Summary of the Inventive Concept
A next-generation system for personalized gut microbiome modulation and iron supplement delivery, leveraging machine learning, wearable devices, and virtual reality platforms to optimize individual health outcomes.
Background and Problem Solved
The original patent disclosed a Lactiplantibacillus plantarum TCI837 strain for iron supplementation, but it has limitations in terms of individualized dosing and gut microbiome monitoring. The new inventive concept addresses these limitations by introducing a system that adapts to an individual's unique gut environment, provides real-time monitoring, and offers personalized recommendations for iron supplementation and gut health maintenance.
Detailed Description of the Inventive Concept
The system consists of a Lactiplantibacillus plantarum TCI837 strain engineered to adapt to an individual's unique gut environment, a sensor module for real-time gut microbiome monitoring, and a data analytics platform for providing personalized recommendations for iron supplementation and gut health maintenance. The system may also include a wearable device for tracking iron levels and gut microbiome health, a virtual reality platform for educating users about gut microbiome health, and a smart capsule for targeted delivery of Lactiplantibacillus plantarum TCI837 to the gut.
Novelty and Inventive Step
The new claims introduce a paradigm shift in iron supplementation and gut microbiome modulation by integrating machine learning, wearable devices, and virtual reality platforms to provide personalized health solutions. The inventive step lies in the combination of these technologies to create a holistic system that adapts to individual needs and provides real-time monitoring and feedback.
Alternative Embodiments and Variations
Alternative embodiments may include different types of sensors or monitoring devices, varied data analytics platforms, or alternative formulations of the Lactiplantibacillus plantarum TCI837 strain. Variations may also include different modes of delivery, such as oral or topical administration, or different types of wearable devices.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the healthcare and wellness industries, particularly in the areas of personalized nutrition, gut health maintenance, and iron supplementation. The system may be marketed as a premium product for individuals seeking tailored health solutions, with potential partnerships with healthcare providers, nutrition companies, and wellness centers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K35/747 |
| A | A61 | A61K33/26 |
| C | C12 | C12N1/205 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Microbiology, Probiotics, and Medical Biotechnology with a focus on Lactobacillus strains and iron supplementation technologies. Requires advanced knowledge of microbial engineering, nutritional science, and medical device development
Person of Ordinary Skill (PHOSITA) Profile
A researcher or engineer with advanced degrees in microbiology, biotechnology, or biomedical engineering, possessing expertise in probiotic strain development, microbiome analysis, and personalized medical technologies
Obviousness Rationale
A PHOSITA would recognize that the PTD represents a predictable extension of the source patent's core technology by applying standard engineering techniques to enhance the Lactiplantibacillus plantarum TCI837 strain's utility. The integration of machine learning, sensor technologies, and targeted delivery mechanisms represents a logical progression of known biomedical engineering approaches to personalize probiotic interventions. The variations demonstrate standard design choices that would be apparent to a skilled practitioner seeking to optimize the original iron supplementation method.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,583 |
|---|---|
| Title | Lactiplantibacillus plantarum TCI837, methods for using the same, and iron supplement composition having the same |
| Assignee(s) | TCI CO., LTD. |